GenSure C. difficile Rapid Test Series
Empowering Faster Diagnosis. Supporting Better Infection Control.

Clostridioides difficile infection (CDI) remains one of the leading causes of healthcare-associated diarrhea worldwide, especially among hospitalized patients, elderly populations, and patients receiving antibiotic therapy.

With increasing awareness of antimicrobial resistance (AMR) and the growing need for effective infection prevention strategies, early and accurate CDI detection has become critical for timely treatment decisions and hospital infection control.

GenSure introduces a comprehensive C. difficile Rapid Test Series, providing flexible solutions for different clinical needs:

P2408 | C. difficile GDH + Toxin A/B Combo Rapid Test

Comprehensive CDI Evaluation in One Step

✓ Simultaneous detection of GDH, Toxin A and Toxin B
✓ Supports rapid identification of toxigenic C. difficile strains
✓ Helps clinicians make faster treatment decisions

P2409 | C. difficile GDH Rapid Test

Sensitive Screening for C. difficile Colonization

✓ Detects GDH as a sensitive marker of C. difficile presence
✓ Suitable for initial CDI screening workflow
✓ Helps identify patients requiring further evaluation

P2410 | C. difficile Toxin A/B Rapid Test

Targeted Detection of Pathogenic Toxins

✓ Detects clinically relevant Toxin A and Toxin B
✓ Supports confirmation of toxigenic C. difficile infection
✓ Provides actionable diagnostic information

Why Choose GenSure CDI Rapid Test Series?

⏱ Rapid Results in 10 Minutes
Accelerate clinical decision-making and patient management.

🎯 Reliable Performance
Designed for accurate detection of key CDI biomarkers.

🧪 Easy Operation
Simple workflow with minimal training requirements.

🌡 Room Temperature Storage (4–30°C)
Convenient transportation and storage for global markets.

🏥 Ideal for Hospitals, Laboratories & Clinics

Supporting:

Infection control programs
Gastroenterology departments
Emergency departments
Point-of-care testing environments
A Growing Global Healthcare Challenge Requires Faster Solutions

✔ Rising CDI burden associated with antibiotic use and healthcare settings
✔ Early diagnosis helps reduce transmission risk
✔ Rapid testing supports better antimicrobial stewardship
✔ Point-of-care solutions improve efficiency and patient outcomes

GenSure Biotech

Be Accurate. Be Reliable.

Your Trusted Partner in Rapid Diagnostics.